196 related articles for article (PubMed ID: 29145314)
21. Complications of lymphadenectomy for gynecologic cancer.
Achouri A; Huchon C; Bats AS; Bensaid C; Nos C; Lécuru F
Eur J Surg Oncol; 2013 Jan; 39(1):81-6. PubMed ID: 23117018
[TBL] [Abstract][Full Text] [Related]
22. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis.
Shaitelman SF; Chiang YJ; Griffin KD; DeSnyder SM; Smith BD; Schaverien MV; Woodward WA; Cormier JN
Breast Cancer Res Treat; 2017 Apr; 162(2):201-215. PubMed ID: 28012086
[TBL] [Abstract][Full Text] [Related]
23. Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy.
Deura I; Shimada M; Hirashita K; Sugimura M; Sato S; Sato S; Oishi T; Itamochi H; Harada T; Kigawa J
Int J Clin Oncol; 2015 Jun; 20(3):556-60. PubMed ID: 24993674
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis.
McCann GA; Cohn DE; Jewell EL; Havrilesky LJ
Gynecol Oncol; 2015 Feb; 136(2):300-4. PubMed ID: 25478927
[TBL] [Abstract][Full Text] [Related]
25. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors.
Hayes SC; Janda M; Ward LC; Reul-Hirche H; Steele ML; Carter J; Quinn M; Cornish B; Obermair A
Gynecol Oncol; 2017 Sep; 146(3):623-629. PubMed ID: 28624154
[TBL] [Abstract][Full Text] [Related]
26. High Incidence of Erysipelas After Surgical Treatment for Vulvar Carcinoma: An Observational Study.
Leermakers ME; Pleunis N; Boll D; Hermans RH; Ezendam NP; Pijnenborg JM
Int J Gynecol Cancer; 2016 Mar; 26(3):582-7. PubMed ID: 26807636
[TBL] [Abstract][Full Text] [Related]
27. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study.
Carlson JW; Kauderer J; Walker JL; Gold MA; O'Malley D; Tuller E; Clarke-Pearson DL;
Gynecol Oncol; 2008 Jul; 110(1):76-82. PubMed ID: 18482765
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with response to compression-based physical therapy for secondary lower limb lymphedema after gynecologic cancer treatment: a multicenter retrospective study.
Yoshihara M; Kitamura K; Tsuru S; Shimono R; Sakuda H; Mayama M; Tano S; Uno K; Ukai MO; Kishigami Y; Oguchi H; Hirota A
BMC Cancer; 2022 Jan; 22(1):25. PubMed ID: 34980013
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for lower-limb lymphedema after surgery for cervical cancer.
Ohba Y; Todo Y; Kobayashi N; Kaneuchi M; Watari H; Takeda M; Sudo S; Kudo M; Kato H; Sakuragi N
Int J Clin Oncol; 2011 Jun; 16(3):238-43. PubMed ID: 21213009
[TBL] [Abstract][Full Text] [Related]
30. Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.
Lindqvist E; Wedin M; Fredrikson M; Kjølhede P
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():112-121. PubMed ID: 28242470
[TBL] [Abstract][Full Text] [Related]
31. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q
Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427
[TBL] [Abstract][Full Text] [Related]
32. Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study.
Hareyama H; Hada K; Goto K; Watanabe S; Hakoyama M; Oku K; Hayakashi Y; Hirayama E; Okuyama K
Int J Gynecol Cancer; 2015 May; 25(4):751-7. PubMed ID: 25723779
[TBL] [Abstract][Full Text] [Related]
33. Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.
Hyngstrom JR; Chiang YJ; Cromwell KD; Ross MI; Xing Y; Mungovan KS; Lee JE; Gershenwald JE; Royal RE; Lucci A; Armer JM; Cormier JN
Melanoma Res; 2013 Aug; 23(4):290-7. PubMed ID: 23752305
[TBL] [Abstract][Full Text] [Related]
34. Current Status and Progress in the Treatment of Lower Limb Lymphedema After Treatment of Gynecological Oncology.
Zhang H; Kong W; Han C; Liu T; Li J; Song D
Lymphat Res Biol; 2022 Jun; 20(3):308-314. PubMed ID: 34698556
[No Abstract] [Full Text] [Related]
35. Onset and burden of lower limb lymphedema after radical prostatectomy: a cross-sectional study.
Neuberger M; Schmidt L; Wessels F; Linke M; Müller C; Westhoff N; Nuhn P; von Hardenberg J
Support Care Cancer; 2022 Feb; 30(2):1303-1313. PubMed ID: 34477972
[TBL] [Abstract][Full Text] [Related]
36. Swelling among women who need education about leg lymphedema: a descriptive study of lymphedema in women undergoing surgery for endometrial cancer.
Salani R; Preston MM; Hade EM; Johns J; Fowler JM; Paskett EP; Katz ML
Int J Gynecol Cancer; 2014 Oct; 24(8):1507-12. PubMed ID: 25078342
[TBL] [Abstract][Full Text] [Related]
37. Use of lymphoscintigraphy to differentiate primary versus secondary lower extremity lymphedema after surgical lymphadenectomy: a retrospective analysis.
Roman MM; Barbieux R; Nogaret JM; Bourgeois P
World J Surg Oncol; 2018 Apr; 16(1):75. PubMed ID: 29631609
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma.
Tada H; Teramukai S; Fukushima M; Sasaki H
BMC Cancer; 2009 Feb; 9():47. PubMed ID: 19193243
[TBL] [Abstract][Full Text] [Related]
39. Incidence and time path of lymphedema in sentinel node negative breast cancer patients: a systematic review.
Gebruers N; Verbelen H; De Vrieze T; Coeck D; Tjalma W
Arch Phys Med Rehabil; 2015 Jun; 96(6):1131-9. PubMed ID: 25637862
[TBL] [Abstract][Full Text] [Related]
40. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
